Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

71.66 -0.27 (-0.38%)
Streaming Delayed Price Updated: 11:11 AM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
60 61 Next >
Does This New Development Make CVS Stock a Buy or a Sell?
Major changes could soon be coming, but will they drive the stock up? 
Via The Motley Fool
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
The stock could be poised for a turnaround. 
Via The Motley Fool
An Activist Investor Is Interested in CVS; We Take a Look
We also chat about Uber and its quest to become an everything app. 
Via The Motley Fool
This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
 
Via Benzinga
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
 
Via Benzinga
What Analysts Are Saying About CVS Health Stock
 
Via Benzinga
Stock Of The Day: Is It Time To Sell CVS?
The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms. 
Via Benzinga
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes... 
Via Benzinga
Topics Lawsuit
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. 
Via Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace. 
Via MarketBeat
Topics Artificial Intelligence
CVS Health's Options: A Look at What the Big Money is Thinking
 
Via Benzinga
Spotlight on CVS Health: Analyzing the Surge in Options Activity
 
Via Benzinga
Is CVS Health Stock a Buy?
It's been a year to forget for the healthcare company. 
Via The Motley Fool
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15. 
Via Benzinga
Topics Stocks
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. 
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
The FTC is going after these PBMs. Is this an opportunity for investors? 
Via The Motley Fool
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. 
Via Benzinga
Topics Lawsuit
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
Via Benzinga
Topics Lawsuit
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... 
Via Benzinga
Topics Fraud
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
 
Via Benzinga
CVS Subsidiary Oak Street Health Agrees to $60M Settlement in Medicare Kickback Violations
Oak Street Health has agreed to pay $60 million to settle claims that it violated the False Claims Act by providing kickbacks to agents for recruiting seniors to its Medicare Advantage clinics,... 
Via Benzinga
Topics Lawsuit
4 Dividend Stocks to Double Up On Right Now
Dividend investing is a powerful way to build wealth and financial security. 
Via The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addresses fraudulent activities between 2009 and 2020 and includes significant... 
Via Benzinga
Topics Lawsuit Whistleblower
3 Overlooked Stocks With Strong Value and Dividend Potential
Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term. 
Via MarketBeat
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.